Skip to content

Author

P. Bartolucci

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Brief Cognitive Assessment in Sickle Cell Care: Psychometric Properties of the RUDAS Across Two Languages.

Neurocognitive disorders (NCD) are frequent yet underrecognized in adults with sickle cell disease (SCD), and practical strategies for routine cognitive assessment remain limited. We evaluated the psychometric properties of the Rowland Universal Dementia Assessment Scale (RUDAS) in the cognitive evaluation of adults wi...

Sara-Maude Desforges, Kevin H. M. Kuo, M. Couette et al. · 0 citations
Clinical trial Open access Oct 2026

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

BACKGROUND Persistent haemolytic anaemia and recurrent vaso-occlusion drive complications and accelerate mortality in sickle cell disease. Mitapivat, an oral allosteric activator of pyruvate kinase, increases ATP and decreases 2,3-DPG with the potential to improve haemolytic anaemia and reduce sickling. We aimed to eva...

B. Andemariam, K. Kuo, F. Algahtani et al. · 1 citation
Open access Sep 2026

Metabolic dysregulation linked to sickling tendency in sickle cell anemia independent of HbF.

Sickle cell disease (SCD) presents substantial interindividual clinical variability that remains only partially explained by genotype, fetal hemoglobin (HbF), and co-inherited alpha-thalassemia. We investigated whether endogenous metabolites modulate the sickling tendency, independently of HbF. We analyzed 368 steady-s...

S. van der Veen, A. Idrizovic, T. Sanavia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.